FDA inspection
Apex Pharmaceuticals Inc.: FDA inspection ending Apr 18, 2019
FDA inspection 1086635 · Voluntary Action Indicated (VAI) · South Plainfield, NJ
Key facts
| Inspection ID | 1086635 |
|---|---|
| Firm | Apex Pharmaceuticals Inc. |
| FEI number | 3006719767 |
| Address | 3005 Hadley Rd Ste 8 |
| City | South Plainfield |
| State | NJ |
| ZIP | 07080 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Apr 18, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data